skip to main
|
skip to sidebar
生技
Tuesday, January 4, 2011
Inspire Pharmaceuticals暴跌逾55%,因药物实验失败
路透纽约1月3日电---Inspire Pharmaceuticals(ISPH.O: 行情)称,其实验性囊胞性纤维症药物在晚期实验中,未能让患者表现出明显好转的迹象.
周一早盘,Inspire Pharmaceuticals暴跌55.36%报3.75美元.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Resources
关注榜
生物谷
汤姆森科技信息
新药发展动态
fiercebiotech
EP Vantage
gekkowire
Labels
ALTH
(1)
AMGN
(1)
AMLN
(1)
AMRN
(1)
ARIA
(2)
ARNA
(1)
ATHX
(1)
AVEO
(1)
AVNR
(1)
BIIB
(1)
CHPI
(1)
CLDX
(3)
CMED
(1)
CSKI
(1)
DNDN
(7)
EXEL
(2)
HALO
(3)
HGSI
(5)
HLCS
(6)
ICGN
(1)
IMGN
(1)
IMMU
(2)
INCY
(15)
ISPH
(2)
ITMN
(4)
JGBO
(1)
KERX
(2)
MITI
(2)
MNKD
(4)
MYGN
(1)
NKBP
(2)
NYMX
(4)
ONTY
(1)
ONXX
(1)
OPK
(1)
OREX
(2)
PARD
(1)
PRE/VIEW
(2)
RIGL
(2)
SCR
(1)
SGEN
(11)
SPPI
(1)
SVA
(1)
TRGT
(9)
TTNP.PK
(1)
VNDA
(1)
VPHM
(2)
VRTX
(2)
VVUS
(7)
WATCHLIST
(2)
XNPT
(4)
XOMA
(1)
ZGEN
(2)
Search This Blog
Blog Archive
▼
2011
(16)
►
May
(1)
►
April
(9)
►
March
(3)
▼
January
(3)
2010年里程碑式创新药物回顾及2011年新药研发前景分析
Inspire Pharmaceuticals暴跌逾55%,因药物实验失败
国际医药市场新药研发前景展望
►
2010
(35)
►
December
(6)
►
September
(1)
►
July
(6)
►
June
(2)
►
May
(7)
►
April
(3)
►
March
(4)
►
February
(1)
►
January
(5)
►
2009
(55)
►
December
(9)
►
November
(2)
►
October
(22)
►
September
(20)
►
June
(1)
►
March
(1)
Followers
No comments:
Post a Comment